Cell signal transduction: hormones, neurotransmitters and therapeutic drugs relate to purine nucleotide structure

References

• Johnston CA, Siderovski DP. Receptor-mediated activation of heterotrimeric G-proteins: current structural insights. Mol Pharmacol. 2007;72:219–230.
   PubMed Web of Science ®Google Scholar
• Hattori M, Gouaux E. Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature. 2012;485:207–212.
   PubMed Web of Science ®Google Scholar
• Moreau A, Gosselin-Badaroudine P, Chahine M. Biophysics, pathophysiology and pharmacology of ion channel gating pores. Front Pharmacol. 2014;5:53.
   PubMed Web of Science ®Google Scholar
• Lyon AM, Taylor VG, Tesmer JJG. Strike a pose: Gaq complexes at the membrane. Trends Pharmacol Sci. 2014;35:23–30.
   PubMed Web of Science ®Google Scholar
• Southan C, Sharman JL, Benson HE, et al. The IUPHAR/BPS Guide to Pharmacology in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res. 2016;44:1037.
   Web of Science ®Google Scholar
• Berger AL, Ikuma M, Welsh MJ. Normal gating of CTFR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain. Proc Natl Acad Sci USA. 2005;102:455–460.
   PubMed Web of Science ®Google Scholar
• Principalli MA, Dupuis JP, Moreau CJ, et al. Kir6.2 activation by sulphoylurea receptors: a different mechanism of action for SUR1 and SUR2A subunits via the same residues. Physiol Rep. 2015; 3:e12533.
   PubMed Web of Science ®Google Scholar
• Li Y, Gao J, Lu Z, et al. Intracellular ATP binding is required to activate the slowly activating K+ channel Iks. Proc Natl Acad Sci USA. 2013;110:18924–18927.
   Web of Science ®Google Scholar
• Harvey RD, Hell JW. Cav 1.2 signaling complexes in the heart. J Mol Cell Cardiol. 2013;58:143–152.
   PubMed Web of Science ®Google Scholar
• Montoliu C, Llansola M, Monfort P, et al. Role of nitric oxide and cyclic GMP in glutamate-induced neuronal death. Neurotox Res. 2001;3:179–188.
   PubMedGoogle Scholar
• Cervetto C, Maura G, Marcoli M. Inhibition of presynaptic release-facilitatory kainate autoreceptors by extracellular cyclic GMP. J Pharm Exp Ther. 2010; 332:210–219.
   PubMed Web of Science ®Google Scholar
• Cabrera-Pastor A, Malaguarnera M, Taoro-Gonzalez L, et al. Extracellular cGMP modulates learning biphasically by modulating glycine receptors, CaMKil and glutamate-nitric-oxide-cGMP pathway. Sci Rep. 2016;6:srep33124.
   Web of Science ®Google Scholar
• Albrecht P, Henke N, Tien ML, et al. Extracellular cyclic GMP and its derivatives GMP and guanosine protect from oxidative glutamate toxicity. Neurochem Int. 2013; 62:610–619.
   PubMed Web of Science ®Google Scholar
• Jakubik J, Janickova H, El-Fakahany EE. Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy. Br J Pharmacol. 2011;1672:1029–1044.
   Google Scholar
• King JR, Nordman JC, Bridges SP, et al. Identification and characterization of a G protein-binding cluster in α7 nicotinic acetylcholine receptors. J Biol Chem. 2015;290:20060–20070.
   PubMed Web of Science ®Google Scholar
• Sakuta H, Okamoto K. Inhibition by imidazoline and imidazolidine derivatives of glibenclamide-sensitive K + currents in Xenopus oocytes. Eur J Pharmacol. 1994;259:223–231.
   PubMed Web of Science ®Google Scholar
• Kesters D, Thompson AJ, Brams M, et al. Structural basis of ligand recognition in 5-HT3 receptors. EMBO Rep. 2013;14:49–56.
   PubMed Web of Science ®Google Scholar
• Peters JU, Hert J, Hillebrecht A, et al. Can we discover pharmacological promiscuity early in the drug discovery process? Drug Discov Today. 2012;17:325–335.
   PubMed Web of Science ®Google Scholar
• Bianchi MT. Promiscuous modulation of ion channels by anti-psychotic and anti-dementia medications. Med Hypotheses. 2010;74:297–300.
   PubMed Web of Science ®Google Scholar
• Williams WR. Relative similarity within purine nucleotide and ligand structures operating on nitric oxide synthetase, guanylyl cyclase and potassium (KATP, BKCa) channels. J Pharm Pharmacol. 2011;63:95–105.
   PubMed Web of Science ®Google Scholar
• Habuchi Y, Tanaka H, Yamamoto T, et al. The mechanisms underlying heart stimulation by dopamine, with special reference to direct and indirect beta adrenoceptor stimulation. Clin Exp Hypertens. 1997;19:141–154.
   PubMed Web of Science ®Google Scholar
• Li S, Wong AHC, Liu F. Ligand-gated ion channel interacting proteins and their role in neuroprotection. Front Cell Neurosci. 2014;8:125. doi: 10.3389/fncel.2014.00125
   PubMed Web of Science ®Google Scholar
• Pepicelli O, Brescia A, Gherzi E, et al. GABA(A), but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in the rat cerebral cortex. Neuropharmacology. 2004;46:480–489.
   PubMed Web of Science ®Google Scholar
• Cabrera-Pastor A, Taoro-Gonzalez L, Felipo V. Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo. J Neurochem. 2016;137:539–548.
   PubMed Web of Science ®Google Scholar
• Miranda-Morales M, Garcia-Hemandez LM, Ochoa-Cortes F, et al. Cross-talking between 5-HT3 and GABAA receptors in cultured myenteric neurons. Synapse. 2007;61:732–740.
   PubMed Web of Science ®Google Scholar
• Dougherty JJ, Nichols RA. Cross-regulation between colocalized nicotinic acetylcholine and 5-HT3 serotonin receptors on presynaptic nerve terminals. Acta Pharmacol Sin. 2009;30:788–794.
   PubMed Web of Science ®Google Scholar
• Simmonds MA, Turner JP. Antagonism of inhibitory amino acids by the steroid derivative RU5135. Br J Pharmacol. 1985; 84:631–635.
   PubMed Web of Science ®Google Scholar
• Pehrson AL, Sanchez C. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction. CNS Spectr. 2014;19:121–133.
   PubMed Web of Science ®Google Scholar
• Shen L, Cui W, Chen R, et al. Differential modulation of GABAA and NMDA receptors by α7-nicotinic receptor desensitization in cultured rat hippocampal neurons. Acta Pharmacol Sin. 2016;37:312–321.
   PubMed Web of Science ®Google Scholar
• Potapenko ES, Biancardi VC, Zhou Y, et al. Astrocytes modulate a postsynaptic NMDA-GABAA – receptor crosstalk in hypothalamic neurosecretory neurons. J Neurosci. 2013;33:631–640.
   PubMed Web of Science ®Google Scholar
• Huang R-Q, Bell-Horner CL, Dibas MI, et al. Pentylenetetrazole-induced inhibition of recombinant γ-aminobutyric acid type A (GABAA) receptors: mechanism and site of action. J Pharm Exp Ther. 2001;298:986–995.
   PubMed Web of Science ®Google Scholar
• Jenkins A, Lobo IA, Gong D, et al. General anesthetics have additive actions on three ligand-gated ion channels. Anesth Analg. 2008;107:486–493.
   PubMed Web of Science ®Google Scholar
• Bianchi MT, Botzolakis EJ, Lagrange AH, et al. Benzodiazepine modulation of GABAA receptor opening frequency depends on activation context: a patch clamp and simulation study. Epilepsy Res. 2009;85:212–220.
   PubMed Web of Science ®Google Scholar
• Sinha S, Sinharoy P, Bratz IN, et al. Propofol causes vasodilation in vivo via TRPA1 ion channels: role of nitric oxide and BKca channels. PLoS One. 2015;10:e0122189.
   PubMed Web of Science ®Google Scholar
• White RE, Han G, Maunz M, et al. Endothelium-independent effect of estrogen on Ca2+-activated K+ channels in human coronary artery smooth muscle cells. Cardiovasc Res. 2002;53:650–661.
   PubMed Web of Science ®Google Scholar
• Zhou X-B, Wulfsen I, Utku E, et al. Dual role of protein kinase C on BK channel regulation. Proc Natl Acad USA. 2005;102:455–460.
   PubMed Web of Science ®Google Scholar
• Hristov KL, Smith AC, Parajuli SP, et al. Large-conductance voltage- and Ca2+ -activated K+ channel regulation by protein kinase C in guinea pig urinary bladder smooth muscle. Am J Physiol Cell Physiol. 2014;306:C460–C470.
   PubMed Web of Science ®Google Scholar
• KIlfoil PJ, Tipparaju SM, Barski OA, et al. Regulation of ion channels by pyridine nucleotides. Circ Res. 2013;112:721–741.
   PubMed Web of Science ®Google Scholar
• Almanza A, Navarrete F, Vega R, et al. Modulation of voltage-gated Ca2+ current in vestibular hair cells by nitric oxide. J Neurophysiol. 2007;97:1188–1195.
   PubMed Web of Science ®Google Scholar
• Sasaki S, Siragy HM, Gildea JJ, et al. Production and role of extracellular guanosine cyclic 3’,5’ monophosphate in sodium uptake in human proximal tubule cells. Hypertension. 2004;43:286–291.
   PubMed Web of Science ®Google Scholar
• Ji H-L, Nie HG, Chang Y, et al. CPT-cGMP is a new ligand of epithelial sodium channels. Int J Biol Sci. 2016;12:359–366.
   PubMed Web of Science ®Google Scholar
• Matavelli LC, Siragy HM. Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats. J Cardiovasc Pharmacol. 2013; 61:17–22.
   PubMed Web of Science ®Google Scholar
• Hofmann F, Biel M, Kaupp UB. International Union of Pharmacology. LI. Nomenclature and structure–function relationships of cyclic nucleotide-regulated channels. Pharmacol Rev. 2005;57:455–462.
   PubMed Web of Science ®Google Scholar
• Zhao CY, Greenstein JL, Winslow RL. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network. J Mol Cell Cardiol. 2016;91:215–227.
   PubMed Web of Science ®Google Scholar
• Chung KY, Rasmussen SGF, Liu T, et al. β2 adrenergic receptor-induced conformational changes in the heterotrimeric G protein Gs. Nature. 2012;477:611–615.
   Web of Science ®Google Scholar
• Kowal J, Chami M, Baumgartner P, et al. Ligand-induced structural changes in the cyclic nucleotide-modulated potassium channel MloK1. Nat Commun. 2014;5:3106 e4106.
   PubMed Web of Science ®Google Scholar